Hirangi Mukhi, BS | Authors

Articles

Can Just-in-Time Clinical Trials Reduce Disparities in Participation?

August 16, 2022

Just-in-time trials are 1 tool capable of rapidly increasing access to clinical trials to develop drugs that treat the diverse and unique tapestry of patients across the United States, especially patients with more diverse racial, ethnic, and socioeconomic backgrounds.

Incorporating Biomarker Testing in Community Cancer Clinics: A Real-World Pilot Study

May 16, 2022

Although there is tremendous excitement about boundaries of science stretching beyond human imagination, realizing the real-world impact of scientific advancement on the health outcomes of patients provides a reality check on how far we still must go.

Differentiating Pseudoprogression From Hyperprogression in Patients Treated With Immunotherapies

February 14, 2022

Advances in the field have also led to the recognition of other clinical challenges, including unforeseen observations and complications associated with choosing the sequencing of appropriate therapeutic interventions as well as the management of drug-related complications.

Despite Advances in Precision Medicine, Disparities Persist

November 23, 2020

The goal of precision medicine is to advance medical and scientific discoveries while offering more tailored, precise, and accurate health interventions, thus maximizing health benefits for patients while reducing adverse effects and overall cost of care.